Chitotriosidase: A New Inflammatory Marker in Diabetic Complications

被引:23
|
作者
Di Rosa, Michelino [1 ]
Malaguarnera, Lucia [1 ]
机构
[1] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Via Androne 83, IT-95124 Catania, Italy
关键词
Diabetes mellitus; Chitotriosidase; Macrophage activation; Inflammation; Endothelial dysfunction; VESSEL WALL INTERACTIONS; FATTY LIVER-DISEASE; ALZHEIMERS-DISEASE; KUPFFER CELLS; ENDOTHELIAL-CELLS; HUMAN MACROPHAGES; GAUCHER-DISEASE; ATHEROSCLEROSIS; EXPRESSION; GENE;
D O I
10.1159/000443932
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chitotriosidase (CHIT1) belongs to chitinase family. So far this enzyme has been the best investigated human chitinase regarding its biological activity and association with various disorders. In a healthy population, CHIT1 activity is very low and originates in the circulating polymorphonuclear cells. Conversely, during the development of acute/chronic inflammatory disorders, the enzymatic activity of CHIT1 increases significantly. Recently, CHIT1 has also been involved in the pathogenesis of diabetes mellitus (DM). Mounting evidence from experimental studies revealing the increase of CHIT1 levels in pathological conditions, such as atherosclerosis, coronary artery disease, acute ischemic stroke, cerebrovascular dementia, nonalcoholic fatty liver disease, and osteolytic processes suggest its critical role in the evolutions and complications of DM. This review is addressed to provide mechanistic insights by highlighting the relationship between CHIT1 and diabetes, and their contribution in the exacerbation of this disease. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:211 / 219
页数:9
相关论文
共 50 条
  • [21] Can chitotriosidase be a surrogate marker for invasive fungal disease?
    Coskun, O.
    Ozturk, M.
    Erdem, H.
    Gumral, R.
    Yaman, H.
    Karakas, A.
    Eyigun, C. P.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E321 - E321
  • [22] New hope for the treatment of diabetic complications
    Corder, R
    [J]. CLINICAL SCIENCE, 2002, 103 (03): : 323 - 324
  • [23] Can chitotriosidase be a surrogate marker for invasive fungal disease?
    Coskun, O.
    Ozturk, M.
    Erdem, H.
    Gumral, R.
    Yaman, H.
    Karakas, A.
    Kilic, S.
    Eyigun, C. P.
    [J]. JOURNAL DE MYCOLOGIE MEDICALE, 2012, 22 (03): : 256 - 260
  • [25] A NEW INTEGRATIVE THEORY OF DIABETIC COMPLICATIONS
    ROBINSON, B
    VANDERJAGT, DL
    TAYLOR, KK
    HUNSAKER, LA
    [J]. CLINICAL RESEARCH, 1992, 40 (01): : A81 - A81
  • [26] Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers
    Cetin, Ece Unal
    Kamis, Fatih
    Cetin, Adil Ugur
    Beyazit, Yavuz
    Kekilli, Murat
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (06) : 3038 - 3046
  • [27] A novel marker of systemic inflammation in psoriasis and related comorbidities: chitotriosidase
    Ilanbey, Bilal
    Elmas, Omer Faruk
    Sozmen, Eser Yildirim
    Gunay, Umran
    Demirbas, Abdullah
    Atasoy, Mustafa
    Tursen, Umit
    Lotti, Torello
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (05) : 2318 - 2323
  • [28] Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
    Hudson, BI
    Bucciarelli, LG
    Wendt, T
    Sakaguchi, T
    Lalla, E
    Qu, W
    Lu, Y
    Lee, L
    Stern, DM
    Naka, Y
    Ramasamy, R
    Yan, SD
    Yan, SF
    D'Agati, V
    Schmidt, AM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 419 (01) : 80 - 88
  • [29] Is urotensin II a new inflammatory marker of inflammatory bowel disease?
    Vernero, Marta
    [J]. MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (03) : 173 - 174
  • [30] Is chitotriosidase a neoplastic marker of activity in chronic myeloproliferative disorders (CMD)?
    Giraldo, P
    Cenarro, A
    Pocovi, M
    Arroyo, A
    RubioFelix, D
    Giralt, M
    [J]. BLOOD, 1997, 90 (10) : 4064 - 4064